Find your next paid study

Case Comprehensive Cancer CenterNCT06101069

Actual pay is set by the research site.

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in …

Brain Tumor, PrimaryBrain Metastases, Adult

Duke UniversityNCT05480644

Actual pay is set by the research site.

Observational

REMASTer: REcurrent Brain Metastases After SRS Trial

Randomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of firs…

Brain MetastasesRadiation NecrosisRecurrent Tumor+1 more

Monteris MedicalNCT05124912

~$10 – $1,125

Actual pay is set by the research site.

Brain MetastasesRenal Cell Carcinoma

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

A Phase II Study of Nivolumab with Ipilimumab and Cabozantinib in Patients with Untreated Renal Cell Carcinoma Brain Metastases

M.D. Anderson Cancer CenterNCT05048212

~$75 – $2,000

Actual pay is set by the research site.

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique (ONCO-RT) - A Phase II Trial of Upfront Pulsed Reduced Dose Rate Whole-Brain Radiation Therapy for Brain Metastases

Study patients will receive Whole-brain radiation therapy (WBRT) - pulsed reduced dose rate (PRDR) within 14 days of registration. All patients will receive si…

Brain Metastases

Medical College of WisconsinNCT05045950

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

To find the highest dose of NK cells that can be given by vein and intraperitoneally (given directly into the abdominal cavity) in combination with cetuximab t…

Colorectal CancerPeritoneal MetastasesCarcinomatosis

M.D. Anderson Cancer CenterNCT07411599

~$150 – $3,000

Actual pay is set by the research site.

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver reg…

Liver CancerLiver Metastases

Maastricht University Medical CenterNCT07717437

Actual pay is set by the research site.

SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more

A Phase II Randomized Open-Label Trial of Levetiracetam for Prevention of Seizures in Patients With Brain Metastases in Primary Motor Cortex

This is a randomized trial for patients with brain metastases in the primary motor cortex who have not had seizures to receive either the prophylactic anti-sei…

Ayal A. Aizer, MDNCT07130786

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase 1, Open-Label, Dose-escalation and Dose-Expansion Study Evaluating AO-252, a Protein-Protein Interaction Inhibitor of TACC3, in Patients With Advanced Solid Tumors With or Without Brain Metastases

The purpose of this study is to assess the safety, tolerability and efficacy of the study drug AO-252 and identify the best dose for use in future studies.

Solid Tumor MalignanciesBrain Metastases From Solid Tumors

A2A Pharmaceuticals Inc.NCT06136884

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

Phase 1 Trial Evaluating the Safety and Tolerability of Gamma Delta T-Cell Infusions in Combination With Low Dose Radiotherapy in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer or Solid Tumors With Bone Metastases

This is a clinical trial studying intravenous infusions of allogeneic gamma delta T cells after receiving low dose radiotherapy in participants with locally ad…

Carcinoma, Non-Small-Cell Lung CancerBone Metastases From Solid Tumors

Kiromic BioPharma Inc.NCT06069570

~$150 – $4,200

Actual pay is set by the research site.

Phase II Trial of Normal Tissue Sparing Whole Brain Radiation Therapy (NTS-WBRT) in Patients With Brain Metastases

This research is being done to assess the quality of life and symptom burden in participants who receive (normal tissue sparing whole brain radiation therapy (…

Brain Metastases

Massachusetts General HospitalNCT05013892

~$75 – $2,000

Actual pay is set by the research site.

Observational

Clinical Investigation to Evaluate the CONVIVO System for Discrimination of Normal From Abnormal Tissue During Brain Tumor Resection

The primary objective of this study is to evaluate the diagnostic performance of the CONVIVO confocal endomicroscope in discriminating between normal and abnor…

GlioblastomaGlial TumorBrain Metastases+3 more